Merck & Co Inc
Change company Symbol lookup
Select an option...
MRK Merck & Co Inc
FUN Cedar Fair LP
NWFFX American Funds New World Fund® Class F-1
CARS Cars.com Inc
AHT Ashford Hospitality Trust Inc
AHII Fyolo Technology Corp
AHH-A Armada Hoffler Properties Inc
AHH Armada Hoffler Properties Inc
AHFD Active Health Foods Inc
AGSO AgriSolar Solutions Inc
Go

Health Care : Pharmaceuticals | Large Cap Value
Company profile

Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices.

Closing Price
$85.81
Day's Change
0.17 (0.20%)
Bid
--
Ask
--
B/A Size
--
Day's High
86.30
Day's Low
84.94
Volume
(Heavy Day)
Volume:
11,744,659

10-day average volume:
9,234,583
11,744,659

MRK's position in the Pharmaceuticals industry

Industry PeersMRKJNJPFELLYZTS

Summary

Company ProfileMerck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through...
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments...
Go to JNJ summary
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes...
Go to PFE summary
Eli Lilly and Company is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health...
Go to LLY summary
Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has...
Go to ZTS summary
52-Week Change

VS. INDUSTRY
2.19%
14.66%
0.33%
34.82%
29.45%
Market Cap

VS. INDUSTRY
$217.0B
$392.8B
$203.5B
$147.5B
$76.4B
Beta

VS. INDUSTRY
0.4
0.7
0.7
0.2
0.7
Dividend Yield

VS. INDUSTRY
2.84%
2.71%
4.15%
1.92%
0.50%
P/E (TTM, GAAP)

VS. INDUSTRY
20.79x
26.76x
14.91x
25.08x
47.58x
Data as of

Fundamentals

Total Revenue (TTM)

VS. INDUSTRY
$47.2B
$80.5B
$49.2B
$22.9B
$6.3B
Profit Margin

VS. INDUSTRY
22.35%
18.49%
28.20%
24.48%
25.49%
Earnings Growth
(5 year, GAAP)

VS. INDUSTRY
-1.06%
-0.24%
14.72%
17.37%
21.80%
Revenue Growth (TTM)

VS. INDUSTRY
6.37%
-1.01%
-8.31%
5.89%
4.86%
Data as of
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2020. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.